mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.4 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
skepinone-L |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.4 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.4 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |